Deerfield Special Situations Fund, L.p. - Net Worth and Insider Trading
Deerfield Special Situations Fund, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deerfield Special Situations Fund, L.p. owns 47 companies in total, including Cabaletta Bio Inc (CABA) , Frequency Therapeutics Inc (FREQ) , and Mirum Pharmaceuticals Inc (MIRM) among others .
Insider Ownership Summary of Deerfield Special Situations Fund, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CABA | Cabaletta Bio Inc | 2019-10-24 | 10 percent owner & other: Possible Member of 10% Group |
| FREQ | Frequency Therapeutics Inc | 2019-10-02 | 10 percent owner & other: Possible Member of 10% Group |
| MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 10 percent owner & other: Possible Member of 10% Group |
 | | 2018-10-22 | 10 percent owner & other: Possible Member of 10% Group |
| | 2019-03-06 | 10 percent owner & other: Possible Member of 10% Group |
| | 2019-02-08 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-09-26 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-07-23 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-07-23 | 10 percent owner & other: Possible member of 10% group |
| | 2018-04-30 | other: *Possible member of 10% group |
| | 2018-05-23 | 10 percent owner & other: *Possible member of 10% group |
| | 2018-02-15 | 10 percent owner & other: Possible Member of 10% Group |
| | 2017-10-04 | 10 percent owner & other: Possible Member of 10% Group |
| | 2014-10-21 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-12-16 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-03-06 | other: Possible Member of 10% Group |
| | 2017-01-24 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-12-12 | 10 percent owner & other: Possible Member of 10% Group |
| | 2014-12-23 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-07-25 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-02-10 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-02-09 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-06-29 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-02-10 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-01-20 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-07-10 | 10 percent owner |
| | 2015-10-07 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-10-07 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-05-11 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-07-28 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-06-16 | 10 percent owner |
| | 2015-05-06 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-03-25 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-02-11 | 10 percent owner & other: Possible Member of 10% Group |
| | 2014-11-21 | 10 percent owner & other: Possible Member of 10% Group |
| | 2014-08-06 | 10 percent owner & other: Possible Members of 10% Group |
| | 2014-07-30 | 10 percent owner & other: Possible Member of 10% Group |
| | 2014-04-22 | 10 percent owner & other: Possible Members of 10% Group |
| | 2012-12-04 | 10 percent owner & other: Possible Member of 10% Group |
| | 2010-11-03 | 10 percent owner & other: Possible Members of 10% Group |
| | 2008-10-27 | 10 percent owner |
| | 2010-08-16 | 10 percent owner & other: Possible Members of 10% Group |
| | 2009-07-13 | 10 percent owner |
| | 2008-03-11 | 10 percent owner |
| | 2006-01-31 | 10 percent owner & other: Possible Members of 10% Group |
| | 2007-11-05 | 10 percent owner & other: Possible Member of 10% Group |
| | 2019-10-02 | 10 percent owner & other: Possible Member of 10% Group |
Deerfield Special Situations Fund, L.p. Trading Performance
Deerfield Special Situations Fund, L.p. Ownership Network
Ownership Network List of Deerfield Special Situations Fund, L.p.
Ownership Network Relation of Deerfield Special Situations Fund, L.p.
Deerfield Special Situations Fund, L.p. Owned Company Details
What does Cabaletta Bio Inc do?
Who are the key executives at Cabaletta Bio Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Cabaletta Bio Inc. Other key executives at Cabaletta Bio Inc include EVP & Science & Technology Gwendolyn Binder , director & President & CEO Steven Nichtberger , and Chief Financial Officer Anup Marda .
Cabaletta Bio Inc (CABA) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Cabaletta Bio Inc (CABA). Other recent insider transactions involving Cabaletta Bio Inc (CABA) include a net sale of 110,000 shares made by Gwendolyn Binder ,
In summary, during the past 3 months, insiders sold 0 shares of Cabaletta Bio Inc (CABA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110,000 shares of Cabaletta Bio Inc (CABA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 110,000 shares.
Cabaletta Bio Inc (CABA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cabaletta Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Frequency Therapeutics Inc do?
Who are the key executives at Frequency Therapeutics Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Frequency Therapeutics Inc. Other key executives at Frequency Therapeutics Inc include director & President and CEO David L. Lucchino , VP Finance & Operations Richard J. Mitrano , and Chief Scientific Officer Christopher R. Loose .
Frequency Therapeutics Inc (FREQ) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Frequency Therapeutics Inc (FREQ). Other recent insider transactions involving Frequency Therapeutics Inc (FREQ) include a net sale of 97,675 shares made by David L. Lucchino , a net sale of 8,202 shares made by Richard J. Mitrano , and a net sale of 26,723 shares made by Christopher R. Loose .
In summary, during the past 3 months, insiders sold 0 shares of Frequency Therapeutics Inc (FREQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 132,600 shares of Frequency Therapeutics Inc (FREQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,600 shares.
Frequency Therapeutics Inc (FREQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Frequency Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Mirum Pharmaceuticals Inc do?
Who are the key executives at Mirum Pharmaceuticals Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include director & 10 percent owner Patrick J Heron , SVP & Global Controller Jolanda Howe , and Chief Scientific Officer Pamela Vig .
Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net purchase of 162,308 shares made by Patrick J Heron , a net sale of 8,512 shares made by Jolanda Howe , and a net sale of 34,606 shares made by Pamela Vig .
In summary, during the past 3 months, insiders sold 0 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 345 shares, with a net purchase of 345 shares. During the past 18 months, 105,850 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 176,308 shares were bought by its insiders, resulting in a net purchase of 70,458 shares.
Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirum Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Aclaris Therapeutics Inc do?
Who are the key executives at Aclaris Therapeutics Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .
Aclaris Therapeutics Inc (ACRS) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net purchase of 4,854,052 shares made by Braden Michael Leonard , a net sale of 18,000 shares made by Joseph Monahan , and a net purchase of 14,705 shares made by James Loerop .
In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 18,000 shares of Aclaris Therapeutics Inc (ACRS) were sold and 4,878,247 shares were bought by its insiders, resulting in a net purchase of 4,860,247 shares.
Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aclaris Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Shockwave Medical Inc do?
Who are the key executives at Shockwave Medical Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Shockwave Medical Inc. Other key executives at Shockwave Medical Inc include Chief Commercial Officer Isaac Zacharias , VP & Finance Trinh Phung , and director & President & CEO Douglas Evan Godshall .
Shockwave Medical Inc (SWAV) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Shockwave Medical Inc (SWAV). Other recent insider transactions involving Shockwave Medical Inc (SWAV) include a net sale of 44,000 shares made by Isaac Zacharias , a net sale of 27,000 shares made by Frank T Watkins , and a net sale of 70,000 shares made by Douglas Evan Godshall .
In summary, during the past 3 months, insiders sold 0 shares of Shockwave Medical Inc (SWAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 213,104 shares of Shockwave Medical Inc (SWAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 213,104 shares.
Shockwave Medical Inc (SWAV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shockwave Medical Inc Insider Transactions
- Download to Excel(.xls)
What does Xeris Biopharma Holdings Inc do?
Who are the key executives at Xeris Biopharma Holdings Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include Chief Financial Officer Steven Pieper , See Remarks Shannon John Patrick Jr , and director & See Remarks Paul R Edick .
Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 25,200 shares made by John P. Schmid , a net purchase of 30,769 shares made by Shannon John Patrick Jr , and a net purchase of 28,000 shares made by Steven Pieper .
In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 104,779 shares were bought by its insiders, resulting in a net purchase of 104,779 shares.
Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xeris Biopharma Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does Arvinas Inc do?
Who are the key executives at Arvinas Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Arvinas Inc. Other key executives at Arvinas Inc include Chief Accounting Officer David K Loomis , Chief Medical Officer Ronald Peck , and Chief Financial Officer Sean A Cassidy .
Arvinas Inc (ARVN) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Arvinas Inc (ARVN). Other recent insider transactions involving Arvinas Inc (ARVN) include a net sale of 3,023 shares made by Ronald Peck , a net sale of 5,196 shares made by John G Houston , and a net sale of 1,702 shares made by Sean A Cassidy .
In summary, during the past 3 months, insiders sold 460 shares of Arvinas Inc (ARVN) in total and bought 0 shares, with a net sale of 460 shares. During the past 18 months, 12,082 shares of Arvinas Inc (ARVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 12,082 shares.
Arvinas Inc (ARVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arvinas Inc Insider Transactions
- Download to Excel(.xls)
What does Aerie Pharmaceuticals Inc do?
Who are the key executives at Aerie Pharmaceuticals Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Aerie Pharmaceuticals Inc. Other key executives at Aerie Pharmaceuticals Inc include Chief Financial Officer Peter Frederick Lang , director & Chief Executive Officer Raj Kannan , and Vice President of Finance Jeffrey Calabrese .
Aerie Pharmaceuticals Inc (AERI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc (AERI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc (AERI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aerie Pharmaceuticals Inc (AERI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerie Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Constellation Pharmaceuticals Inc do?
Who are the key executives at Constellation Pharmaceuticals Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible member of 10% group of Constellation Pharmaceuticals Inc. Other key executives at Constellation Pharmaceuticals Inc include Chief Financial Officer Emma Reeve , 10 percent owner Column Group L P , and See Remarks Karen Valentine .
Constellation Pharmaceuticals Inc (CNST) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Constellation Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Deerfield Special Situations Fund, L.p. is the other: *Possible member of 10% group of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 4,000 shares made by Thomas S Mchugh , and a net purchase of 14,000 shares made by Geoffrey Michael Glass .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 41,000 shares were bought by its insiders, resulting in a net sale of 62,975 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
- Download to Excel(.xls)
What does Kiniksa Pharmaceuticals International PLC do?
Who are the key executives at Kiniksa Pharmaceuticals International PLC?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: *Possible member of 10% group of Kiniksa Pharmaceuticals International PLC. Other key executives at Kiniksa Pharmaceuticals International PLC include director & 10 percent owner & Chairman & CEO Sanj K Patel , Chief Business Officer Eben Tessari , and Group VP & Rilonacept GM Ross Moat .
Kiniksa Pharmaceuticals International PLC (KNSA) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 150,848 shares made by John Paolini , a net sale of 309,021 shares made by Sanj K Patel , and a net sale of 52,000 shares made by Eben Tessari .
In summary, during the past 3 months, insiders sold 270,759 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 270,759 shares. During the past 18 months, 628,724 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 628,724 shares.
Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiniksa Pharmaceuticals International PLC Insider Transactions
- Download to Excel(.xls)
What does Catalyst Biosciences Inc do?
Who are the key executives at Catalyst Biosciences Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .
Catalyst Biosciences Inc (CBIO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Rhythm Pharmaceuticals Inc do?
Who are the key executives at Rhythm Pharmaceuticals Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Human Resources Officer Pamela J. Cramer , Chief Technical Officer Joseph Shulman , and Corporate Controller & CAO Christopher Paul German .
Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 171,662 shares made by Joseph Shulman , a net sale of 85,162 shares made by Pamela J. Cramer , and a net sale of 78,894 shares made by Jennifer Chien .
In summary, during the past 3 months, insiders sold 125,174 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 125,174 shares. During the past 18 months, 592,041 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 592,041 shares.
Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rhythm Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Protara Therapeutics Inc do?
Who are the key executives at Protara Therapeutics Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include 10 percent owner Opaleye Management Inc. , Chief Financial Officer Patrick Fabbio , and director & CEO and President Jesse Shefferman .
Protara Therapeutics Inc (TARA) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 703,460 shares made by Opaleye Management Inc. ,
In summary, during the past 3 months, insiders sold 220,893 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 220,893 shares. During the past 18 months, 703,460 shares of Protara Therapeutics Inc (TARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 703,460 shares.
Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protara Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Societal CDMO Inc do?
Who are the key executives at Societal CDMO Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Societal CDMO Inc. Other key executives at Societal CDMO Inc include director & Chief Executive Officer Enloe J David Jr , director & 10 percent owner Mathew Paul Arens , and 10 percent owner Awm Investment Company, Inc. .
Societal CDMO Inc (SCTL) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Societal CDMO Inc (SCTL). Other recent insider transactions involving Societal CDMO Inc (SCTL) include a net purchase of 6,250,000 shares made by Mathew Paul Arens , a net purchase of 140,000 shares made by Awm Investment Company, Inc. , and a net purchase of 125,000 shares made by Enloe J David Jr .
In summary, during the past 3 months, insiders sold 0 shares of Societal CDMO Inc (SCTL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Societal CDMO Inc (SCTL) were sold and 6,792,222 shares were bought by its insiders, resulting in a net purchase of 6,792,222 shares.
Societal CDMO Inc (SCTL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Societal CDMO Inc Insider Transactions
- Download to Excel(.xls)
What does eHealth Inc do?
Who are the key executives at eHealth Inc?
Deerfield Special Situations Fund, L.p. is the other: Possible Member of 10% Group of eHealth Inc. Other key executives at eHealth Inc include SVP & General Counsel & Secr. Gavin G. Galimi , SVP & Chief Financial Officer John J Stelben , and director & Chief Executive Officer Soistman Francis S Jr .
eHealth Inc (EHTH) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in eHealth Inc (EHTH). Other recent insider transactions involving eHealth Inc (EHTH) include a net purchase of 24,865 shares made by Gavin G. Galimi , a net purchase of 27,932 shares made by Dale B Wolf , and a net purchase of 50,000 shares made by Soistman Francis S Jr .
In summary, during the past 3 months, insiders sold 0 shares of eHealth Inc (EHTH) in total and bought 7,000 shares, with a net purchase of 7,000 shares. During the past 18 months, 0 shares of eHealth Inc (EHTH) were sold and 122,797 shares were bought by its insiders, resulting in a net purchase of 122,797 shares.
eHealth Inc (EHTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
eHealth Inc Insider Transactions
- Download to Excel(.xls)
What does CAS Medical Systems Inc do?
Who are the key executives at CAS Medical Systems Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of CAS Medical Systems Inc. Other key executives at CAS Medical Systems Inc include director & President and CEO Thomas M Patton , director & 10 percent owner James E Thomas , and 10 percent owner Thomas, Mcnerney & Partners Ii L.p. .
CAS Medical Systems Inc (CASM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CAS Medical Systems Inc (CASM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CAS Medical Systems Inc (CASM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CAS Medical Systems Inc (CASM)'s detailed insider trading history can be found in Insider Trading Tracker table.
CAS Medical Systems Inc Insider Transactions
- Download to Excel(.xls)
What does Invuity Inc do?
Who are the key executives at Invuity Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Invuity Inc. Other key executives at Invuity Inc include Chief Financial Officer James H Mackaness , 10 percent owner & other: Possible Member of 10% Group James E Flynn , and 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) .
Invuity Inc (IVTY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Invuity Inc (IVTY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Invuity Inc (IVTY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Invuity Inc (IVTY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Invuity Inc Insider Transactions
- Download to Excel(.xls)
What does Vanda Pharmaceuticals Inc do?
Who are the key executives at Vanda Pharmaceuticals Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Vanda Pharmaceuticals Inc. Other key executives at Vanda Pharmaceuticals Inc include VP & Acting CFO & Treasurer Kevin Patrick Moran , director & Chief Executive Officer Mihael Hristos Polymeropoulos , and SVP & General Counsel Timothy Williams .
Vanda Pharmaceuticals Inc (VNDA) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Vanda Pharmaceuticals Inc (VNDA). Other recent insider transactions involving Vanda Pharmaceuticals Inc (VNDA) include a net sale of 35,163 shares made by Kevin Patrick Moran , a net sale of 31,688 shares made by Timothy Williams , and a net sale of 20,451 shares made by Joakim Wijkstrom .
In summary, during the past 3 months, insiders sold 0 shares of Vanda Pharmaceuticals Inc (VNDA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 166,385 shares of Vanda Pharmaceuticals Inc (VNDA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 166,385 shares.
Vanda Pharmaceuticals Inc (VNDA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vanda Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Audentes Therapeutics Inc do?
Who are the key executives at Audentes Therapeutics Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Audentes Therapeutics Inc. Other key executives at Audentes Therapeutics Inc include President and COO Natalie C. Holles , SVP & Chief Medical Officer Edward R. Conner , and Executive Vice President & CFO Thomas P Soloway .
Audentes Therapeutics Inc (BOLD) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Audentes Therapeutics Inc (BOLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Audentes Therapeutics Inc (BOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Audentes Therapeutics Inc (BOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Audentes Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Axogen Inc do?
Who are the key executives at Axogen Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Axogen Inc. Other key executives at Axogen Inc include Chief R&D Officer Angelo Scopelianos , director & CEO Karen L. Zaderej , and VP & Clinical&Translational Sc Erick Wayne Devinney .
Axogen Inc (AXGN) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Axogen Inc (AXGN). Other recent insider transactions involving Axogen Inc (AXGN) include a net sale of 74,448 shares made by Gregory Gene Freitag , a net sale of 42,343 shares made by Michael Patrick Donovan , and a net sale of 39,280 shares made by Karen L. Zaderej .
In summary, during the past 3 months, insiders sold 0 shares of Axogen Inc (AXGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 180,030 shares of Axogen Inc (AXGN) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 150,030 shares.
Axogen Inc (AXGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axogen Inc Insider Transactions
- Download to Excel(.xls)
What does Larimar Therapeutics Inc do?
Who are the key executives at Larimar Therapeutics Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .
Larimar Therapeutics Inc (LRMR) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Larimar Therapeutics Inc (LRMR). Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 57,208 shares made by Thomas Edward Hamilton , and a net purchase of 5,000 shares made by Carole Ben-maimon .
In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,367,575 shares were bought by its insiders, resulting in a net purchase of 4,367,575 shares.
Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Larimar Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Financial Officer Jason Haas , Chief Commercial Officer Chee Conley , and Chief Medical Officer David Roth .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net purchase of 100,000 shares made by Jason Haas .
In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 200,000 shares, with a net purchase of 200,000 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 1,073,765 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does AveXis Inc do?
Who are the key executives at AveXis Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of AveXis Inc. Other key executives at AveXis Inc include director & President & CEO Sean P. Nolan , 10 percent owner Ag Novartis , and Chief Financial Officer Phillip B. Donenberg .
AveXis Inc (AVXS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AveXis Inc (AVXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AveXis Inc (AVXS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AveXis Inc (AVXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
AveXis Inc Insider Transactions
- Download to Excel(.xls)
What does XenoPort Inc do?
Who are the key executives at XenoPort Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of XenoPort Inc. Other key executives at XenoPort Inc include See Remarks William G Harris , 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) , and 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. .
XenoPort Inc (XNPT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of XenoPort Inc (XNPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XenoPort Inc (XNPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
XenoPort Inc (XNPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
XenoPort Inc Insider Transactions
- Download to Excel(.xls)
What does Streamline Health Solutions Inc do?
Who are the key executives at Streamline Health Solutions Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner of Streamline Health Solutions Inc. Other key executives at Streamline Health Solutions Inc include President Benjamin Louis Stilwill , Interim CFO Reeves Bryant J Iii , and Chief People Officer Wendy L Lucio .
Streamline Health Solutions Inc (STRM) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Streamline Health Solutions Inc (STRM). Other recent insider transactions involving Streamline Health Solutions Inc (STRM) include a net purchase of 6,300 shares made by Benjamin Louis Stilwill ,
In summary, during the past 3 months, insiders sold 0 shares of Streamline Health Solutions Inc (STRM) in total and bought 420 shares, with a net purchase of 420 shares. During the past 18 months, 0 shares of Streamline Health Solutions Inc (STRM) were sold and 420 shares were bought by its insiders, resulting in a net purchase of 420 shares.
Streamline Health Solutions Inc (STRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Streamline Health Solutions Inc Insider Transactions
- Download to Excel(.xls)
What does Alimera Sciences Inc do?
Who are the key executives at Alimera Sciences Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Alimera Sciences Inc. Other key executives at Alimera Sciences Inc include 10 percent owner Caligan Partners Lp , other: Chairman Emeritus C. Daniel Myers , and 10 percent owner David Edward Johnson .
Alimera Sciences Inc (ALIM) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Alimera Sciences Inc (ALIM). Other recent insider transactions involving Alimera Sciences Inc (ALIM) include a net sale of 0 shares made by Caligan Partners Lp , and a net purchase of 1,401,901 shares made by Adam Morgan .
In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc (ALIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 579,000 shares of Alimera Sciences Inc (ALIM) were sold and 1,980,901 shares were bought by its insiders, resulting in a net purchase of 1,401,901 shares.
Alimera Sciences Inc (ALIM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alimera Sciences Inc Insider Transactions
- Download to Excel(.xls)
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 19,012 shares made by Lloyd A Rowland .
In summary, during the past 3 months, insiders sold 28,425 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 28,425 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Antares Pharma Inc do?
Who are the key executives at Antares Pharma Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Antares Pharma Inc. Other key executives at Antares Pharma Inc include See Remarks Peter C Richardson , Executive Vice President & CFO Fred M Powell , and See Remarks Peter J Graham .
Antares Pharma Inc (ATRS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc (ATRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc (ATRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antares Pharma Inc (ATRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antares Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Neos Therapeutics Inc do?
Who are the key executives at Neos Therapeutics Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Neos Therapeutics Inc. Other key executives at Neos Therapeutics Inc include director & Chief Executive Officer Gerald W. Mclaughlin , Chief Financial Officer Richard I Eisenstadt , and SVP & General Counsel John M Limongelli .
Neos Therapeutics Inc (NEOS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc (NEOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc (NEOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Neos Therapeutics Inc (NEOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neos Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Alpine Immune Sciences Inc do?
Who are the key executives at Alpine Immune Sciences Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner of Alpine Immune Sciences Inc. Other key executives at Alpine Immune Sciences Inc include Senior VP and CFO James Paul Rickey , director & Executive Chairman and CEO Mitchell Gold , and director & 10 percent owner Xiangmin Cui .
Alpine Immune Sciences Inc (ALPN) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Orbimed Advisors Llc .
In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,587,529 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,529 shares.
Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alpine Immune Sciences Inc Insider Transactions
- Download to Excel(.xls)
What does aTyr Pharma Inc do?
Who are the key executives at aTyr Pharma Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of aTyr Pharma Inc. Other key executives at aTyr Pharma Inc include Chief Financial Officer Jill Marie Broadfoot , Chief Medical Officer Sanjay Shukla , and See Remarks Nancy Krueger .
aTyr Pharma Inc (ATYR) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in aTyr Pharma Inc (ATYR). Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 65,000 shares made by Sanjay Shukla , a net purchase of 3,410 shares made by Jill Marie Broadfoot , and a net purchase of 100,000 shares made by Paul Schimmel .
In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,590 shares of aTyr Pharma Inc (ATYR) were sold and 225,000 shares were bought by its insiders, resulting in a net purchase of 223,410 shares.
aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.
aTyr Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does SteadyMed Ltd do?
Who are the key executives at SteadyMed Ltd?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of SteadyMed Ltd. Other key executives at SteadyMed Ltd include 10 percent owner Orbimed Advisors Llc , 10 percent owner Orbimed Capital Gp Vi Llc , and director & 10 percent owner Brian Jay Stark .
SteadyMed Ltd (STDY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of SteadyMed Ltd (STDY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SteadyMed Ltd (STDY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
SteadyMed Ltd (STDY)'s detailed insider trading history can be found in Insider Trading Tracker table.
SteadyMed Ltd Insider Transactions
- Download to Excel(.xls)
What does Invitae Corp do?
Who are the key executives at Invitae Corp?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Invitae Corp. Other key executives at Invitae Corp include Chief Financial Officer Ana J. Schrank , Chief Commercial Officer Robert M. Guigley , and See Remarks Robert Iv Dickey .
Invitae Corp (NVTAQ) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Invitae Corp (NVTAQ). Other recent insider transactions involving Invitae Corp (NVTAQ) include a net sale of 90,864 shares made by Kenneth D. Knight , a net sale of 86,904 shares made by Yafei Wen , and a net sale of 33,562 shares made by Robert L Nussbaum .
In summary, during the past 3 months, insiders sold 0 shares of Invitae Corp (NVTAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 266,444 shares of Invitae Corp (NVTAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 266,444 shares.
Invitae Corp (NVTAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Invitae Corp Insider Transactions
- Download to Excel(.xls)
What does Dicerna Pharmaceuticals Inc do?
Who are the key executives at Dicerna Pharmaceuticals Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Dicerna Pharmaceuticals Inc. Other key executives at Dicerna Pharmaceuticals Inc include See Remarks Bob D Brown , EVP & Chief Medical Officer Shreeram Aradhye , and director & President and CEO Douglas Fambrough .
Dicerna Pharmaceuticals Inc (DRNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dicerna Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Loxo Oncology Inc do?
Who are the key executives at Loxo Oncology Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Members of 10% Group of Loxo Oncology Inc. Other key executives at Loxo Oncology Inc include Senior VP of Finance Jennifer Burstein , director & President & CEO Joshua H. Bilenker , and director & 10 percent owner Steve Elms .
Loxo Oncology Inc (LOXO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Loxo Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Adverum Biotechnologies Inc do?
Who are the key executives at Adverum Biotechnologies Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Adverum Biotechnologies Inc. Other key executives at Adverum Biotechnologies Inc include Chief Development Officer Setareh Seyedkazemi , Chief Financial Officer Linda M Rubinstein , and Chief Scientific Officer Brigit Riley .
Adverum Biotechnologies Inc (ADVM) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Adverum Biotechnologies Inc (ADVM). Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 302,064 shares made by Braden Michael Leonard , a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , and a net purchase of 100,000 shares made by Linda M Rubinstein .
In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 620 shares of Adverum Biotechnologies Inc (ADVM) were sold and 335,064 shares were bought by its insiders, resulting in a net purchase of 334,444 shares.
Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adverum Biotechnologies Inc Insider Transactions
- Download to Excel(.xls)
What does TriVascular Technologies Inc do?
Who are the key executives at TriVascular Technologies Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Members of 10% Group of TriVascular Technologies Inc. Other key executives at TriVascular Technologies Inc include 10 percent owner Krishna Kittu Kolluri , VP & Gen. Counsel and Secretary Kimberley A. Elting , and Chief Technology Officer Michael V. Chobotov .
TriVascular Technologies Inc (TRIV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.
TriVascular Technologies Inc Insider Transactions
- Download to Excel(.xls)
What does NxStage Medical Inc do?
Who are the key executives at NxStage Medical Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of NxStage Medical Inc. Other key executives at NxStage Medical Inc include director & Chief Executive Officer Jeffrey H Burbank , Chief Accounting Officer Kevin Hershberger , and 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) .
NxStage Medical Inc (NXTM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of NxStage Medical Inc (NXTM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NxStage Medical Inc (NXTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
NxStage Medical Inc (NXTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
NxStage Medical Inc Insider Transactions
- Download to Excel(.xls)
What does Rigel Pharmaceuticals Inc do?
Who are the key executives at Rigel Pharmaceuticals Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Members of 10% Group of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Financial Officer Dean L Schorno , Sr VP of Bus Dev and Com Ops Raul R Rodriguez , and EVP & Chief Commercial Officer David A Santos .
Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 52,894 shares made by Raul R Rodriguez , a net sale of 14,519 shares made by David A Santos , and a net sale of 12,628 shares made by Dean L Schorno .
In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,004 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,004 shares.
Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rigel Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does NeuroMetrix Inc do?
Who are the key executives at NeuroMetrix Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner of NeuroMetrix Inc. Other key executives at NeuroMetrix Inc include Chief Financial Officer Thomas T Higgins , other: See Explanation in Footnotes Topline Capital Management, Llc , and 10 percent owner Topline Capital Partners, Lp .
NeuroMetrix Inc (NURO) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in NeuroMetrix Inc (NURO). Other recent insider transactions involving NeuroMetrix Inc (NURO) include a net sale of 1,000 shares made by Joshua Horowitz ,
In summary, during the past 3 months, insiders sold 0 shares of NeuroMetrix Inc (NURO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,000 shares of NeuroMetrix Inc (NURO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,000 shares.
NeuroMetrix Inc (NURO)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeuroMetrix Inc Insider Transactions
- Download to Excel(.xls)
What does Fibrocell Science Inc do?
Who are the key executives at Fibrocell Science Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Members of 10% Group of Fibrocell Science Inc. Other key executives at Fibrocell Science Inc include 10 percent owner Randal J Kirk , 10 percent owner Intrexon Corp , and director & Chairman and CEO David Pernock .
Fibrocell Science Inc (FCSC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Fibrocell Science Inc (FCSC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fibrocell Science Inc (FCSC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Fibrocell Science Inc (FCSC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fibrocell Science Inc Insider Transactions
- Download to Excel(.xls)
What does NeurogesX Inc do?
Who are the key executives at NeurogesX Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner of NeurogesX Inc. Other key executives at NeurogesX Inc include President and CEO Ron Martell , Exec. V.P. & COO & CFO Stephen F Ghiglieri , and director & 10 percent owner Robert Nelsen .
NeurogesX Inc (NGSX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of NeurogesX Inc (NGSX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeurogesX Inc (NGSX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
NeurogesX Inc (NGSX)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeurogesX Inc Insider Transactions
- Download to Excel(.xls)
What does Cyclacel Pharmaceuticals Inc do?
Who are the key executives at Cyclacel Pharmaceuticals Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and Chief Medical Officer Mark Kirschbaum .
Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .
In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.
Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclacel Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Dynavax Technologies Corp do?
Who are the key executives at Dynavax Technologies Corp?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Members of 10% Group of Dynavax Technologies Corp. Other key executives at Dynavax Technologies Corp include Principal Accounting Officer Justin Burgess , Chief Medical Officer and VP Robert Janssen , and Senior Vice President David F Novack .
Dynavax Technologies Corp (DVAX) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Dynavax Technologies Corp (DVAX). Other recent insider transactions involving Dynavax Technologies Corp (DVAX) include a net sale of 169,000 shares made by David F Novack , a net sale of 46,327 shares made by Robert Janssen , and a net sale of 3,000,000 shares made by Hack Andrew A. F. .
In summary, during the past 3 months, insiders sold 0 shares of Dynavax Technologies Corp (DVAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,247,529 shares of Dynavax Technologies Corp (DVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,247,529 shares.
Dynavax Technologies Corp (DVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dynavax Technologies Corp Insider Transactions
- Download to Excel(.xls)
What does VIA Pharmaceuticals Inc do?
Who are the key executives at VIA Pharmaceuticals Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of VIA Pharmaceuticals Inc. Other key executives at VIA Pharmaceuticals Inc include 10 percent owner Bay City Capital Llc , 10 percent owner Bay City Capital Fund Iv Co Invesment Fund Lp , and 10 percent owner Bay City Capital Management Iv Llc .
VIA Pharmaceuticals Inc (VIAP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of VIA Pharmaceuticals Inc (VIAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VIA Pharmaceuticals Inc (VIAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
VIA Pharmaceuticals Inc (VIAP)'s detailed insider trading history can be found in Insider Trading Tracker table.
VIA Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Korro Bio Inc do?
Who are the key executives at Korro Bio Inc?
Deerfield Special Situations Fund, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Korro Bio Inc. Other key executives at Korro Bio Inc include Chief Financial Officer Vineet Agarwal , 10 percent owner Scott D Sandell , and 10 percent owner New Enterprise Associates 17, L.p. .
Korro Bio Inc (KRRO) Insider Trades Summary
Over the past 18 months, Deerfield Special Situations Fund, L.p. made no insider transaction in Korro Bio Inc (KRRO). Other recent insider transactions involving Korro Bio Inc (KRRO) include a net sale of 11,016 shares made by Vineet Agarwal , a net sale of 2,124 shares made by David L. Lucchino , and a net purchase of 17,857 shares made by Carmen Chang .
In summary, during the past 3 months, insiders sold 11,016 shares of Korro Bio Inc (KRRO) in total and bought 0 shares, with a net sale of 11,016 shares. During the past 18 months, 13,140 shares of Korro Bio Inc (KRRO) were sold and 178,570 shares were bought by its insiders, resulting in a net purchase of 165,430 shares.
Korro Bio Inc (KRRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Korro Bio Inc Insider Transactions
- Download to Excel(.xls)
Deerfield Special Situations Fund, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Deerfield Special Situations Fund, L.p.. You might contact Deerfield Special Situations Fund, L.p. via mailing address: 780 3rd Avenue, 37th Floor, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
